share_log
Reuters ·  Apr 7 12:00
Corcept Initiates Trial of Relacorilant Plus NAB-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 237

Recommended

Write a comment